[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334279-105":59,"doc-detail-334279-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","potential-therapeutic-strategies-for-colitis-and-colon-cancer-bidirectional-targeting-sting-pathway","Potential therapeutic strategies for colitis and colon cancer - bidirectional targeting STING pathway","","The cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon gene (STING) pathway is presented as a therapeutic target for colitis and colon cancer. Inhibiting STING may reduce colitis progression, while activating STING can strengthen anti-tumor immune responses against colon cancer. This review summarizes STING inhibitors and agonists evaluated for both conditions, detailing their molecular mechanisms and discussing translational potential. It also examines recent progress in STING oligomerization, degradation, and phase separation–dependent self-regulation, proposing druggable targets for next-generation STING modulators.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-therapeutic-strategies-for-colitis-and-colon-cancer-bidirectional-targeting-sting-pathway/334279/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-therapeutic-strategies-for-colitis-and-colon-cancer-bidirectional-targeting-sting-pathway/334279.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the STING pathway considered a therapeutic target for both colitis and colon cancer?","Question",{"text":112,"@type":113},"STING shows dual roles: inhibiting STING can mitigate colitis progression, while activating STING can enhance anti-tumor immune responses in colon cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does STING signaling get activated in the cGAS-STING pathway?",{"text":117,"@type":113},"cGAS binds double-stranded DNA, catalyzes synthesis of 2′-3′-cGAMP, which then binds STING on the ER membrane to induce STING oligomerization and activation.",{"name":119,"@type":110,"acceptedAnswer":120},"What recent mechanisms are highlighted as opportunities for drug development?",{"text":121,"@type":113},"The review focuses on advances in STING oligomerization, degradation, and phase separation–dependent self-regulation, identifying potential druggable targets for developing new STING agonists or inhibitors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334279,1790332537,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review   \nPotential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway  \nJiaorong Qu,a,c Yajie Cai,b,c Fanghong Li,b Xiaojiaoyang Li,a,∗∗ and Runping Liub,∗  \naSchool of Life Sciences, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Beijing, 100029, China  \nbSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Beijing, 100029, China  \nSummary  \nThe cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon gene (STING) pathway has emerged as a promising therapeutic target for colitis and colon cancers. Notably, inhibiting STING may mitigate the progression of colitis, whereas activating STING can enhance anti-tumor immune responses against colon cancer. This duality suggests that the development of STING agonists and inhibitors possesses signiﬁcant clinical translational potential. In this review, we provide a comprehensive overview of STING inhibitors/agonists that have been systematically evaluated in the contexts of colitis and colon cancer and their speciﬁc molecular mechanisms. Other well-characterized STING inhibitors/agonists may also hold considerable promise for the treatment of these conditions, although efﬁcacy validation remain necessary. Additionally, we delve into the latest advances concerning STING oligomerization, degradation and phase separation-dependent self-regulation, proposing potential druggable targets that could inspire the development of novel STING agonists or inhibitors. In Summary, targeting STING appears to be a promising strategy for the treatment of colitis and colon cancer.  \nCopyright © 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \nKeywords: STING; STING inhibitors; STING agonists; Colitis; Colon cancer  \nIntroduction  \nInﬂammatory bowel disease (IBD) is an immunemediated chronic condition that comprises Crohn’s disease (CD), ulcerative colitis (UC) and IBD unclassiﬁed (IBD-U) . The cumulative effects of recurrent acute and chronic inﬂammation underscore a signiﬁcant impact on the development of colon cancers. Recent studies have identiﬁed that the cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon gene (STING) pathway (referred as STING pathway in this review) not only plays a vital role in the progression of colitis but also closely inﬂuences the transformation process of colitis-associated colon cancer. The cGAS-STING pathway responds to both endogenous and exogenous DNA, distinguishing it from other innate immune pathways. The activation ofcGAS occurs through direct binding to double-stranded DNA (dsDNA), triggering catalytic activation in its C-terminal nucleotidyltransferase domain. The resulting cGAS-dsDNA complex undergoes conformational changes, facilitating the synthesis of 2′ -3′ -cGAMP, which acts as a second messenger that binds to STING on the endoplasmic reticulum (ER) membrane, inducing STING oligomerization and activation. Then activated STING recruits  \n*Corresponding author.  \n**Corresponding author.  \nE-mail addresses: [liurunping@bucm.edu.cn](liurunping@bucm.edu.cn) (R. Liu), xiaojiaoyang. [li@bucm.edu.cn](li@bucm.edu.cn) (X. Li).  \ncThese authors contributed equally to this work.  \nTANK binding kinase 1 (TBK1), which phosphorylates IFN regulatory factor 3 (IRF3) to initiate type I IFN responses, while also promoting nuclear factor κB (NF-κB)-driven inﬂammatory cytokine release.1 During the progression of colitis, endogenous or gut microbiota DNA-induced STING-dependent host immune activation, coupled with the accumulation of reactive oxygen species (ROS) resulting from chronic inﬂammation, establishes a vicious cycle that promotes genomic DNA damage and drives carcinogenesis through genetic mutations and epigenetic reprogramming.  \nIn clinical studies, the activation of STING-IRF3 signaling was observed in macro","cbCaicmuoRcxMt6N","https://ap.wps.com/l/cbCaicmuoRcxMt6N","pdf",1475225,12,"English","# Introduction\n## cGAS-STING signaling activation and downstream immune responses\n## STING involvement in colitis and colitis-associated colon cancer\n# Therapeutic strategies: inhibitors and agonists\n## Bidirectional STING targeting rationale\n## Evidence from preclinical and clinical observations\n# Emerging mechanistic directions\n## STING oligomerization, degradation, and phase separation\n## Potential druggable targets","[{\"question\":\"Why is the STING pathway considered a therapeutic target for both colitis and colon cancer?\",\"answer\":\"STING shows dual roles: inhibiting STING can mitigate colitis progression, while activating STING can enhance anti-tumor immune responses in colon cancer.\"},{\"question\":\"How does STING signaling get activated in the cGAS-STING pathway?\",\"answer\":\"cGAS binds double-stranded DNA, catalyzes synthesis of 2′-3′-cGAMP, which then binds STING on the ER membrane to induce STING oligomerization and activation.\"},{\"question\":\"What recent mechanisms are highlighted as opportunities for drug development?\",\"answer\":\"The review focuses on advances in STING oligomerization, degradation, and phase separation–dependent self-regulation, identifying potential druggable targets for developing new STING agonists or inhibitors.\"}]","Potential therapeutic strategies for colitis and colon cancer - bidirectional targeting STING pathway | PDF",1790006100]